Research

Medical Sciences

Title :

To evaluate efficacy of Bacillus calmette-guerin (Bcg) in reducing the incidence & severity of Covid-19 in the high-risk population (Bric)- A Phase III, multicentric, quadruple blind randomized controlled trial

Area of research :

Medical Sciences

Focus area :

Task Force (TF)

Principal Investigator :

Prof. S. Sinha All India Institute of Medical Sciences Delhi

Timeline Start Year :

2020

Timeline End Year :

2021

Details

Total Budget (INR):

 2,00,57,120

Organizations involved

Implementing Agency :

 All India Institute of Medical Sciences Delhi

Funding Agency :

 Indian Council of Medical Research (ICMR)

Related Research

A cross-sectional study on the prevalence of coxiellosis among domestic ruminant population in southern district of Tamil Nadu
A microfluidic based point of care testing device for measuring urine albumin using a novel organic dye
A randomized controlled trial of single-dose oral ivermectin in patients with Covid-19 infection
A study to investigate endothelial dysfunction as preclinical marker for osteoporosis
An open-labelled black box clinical study to investigate efficacy of add on personalized Ayurveda intervention in comparison to stand alone treatment based on ICMR guidelines